CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2017—Applied Spectral Imaging introduced its HiPath imaging and analysis system, which provides computer-assisted PD-L1 interpretation for research use.
HiPath determines PD-L1 protein expression by calculating the percentage of viable tumor cells showing partial or complete membrane staining and automatically provides the tumor proportion score. The system provides digital automation of IHC tissue analysis and allows pathologists to capture images, receive computer-aided scoring, and generate automatic reports with complete case statistics. It is FDA cleared for ER, PR, HER2/neu, and Ki-67 and supports all nuclear and membrane stains.
Applied Spectral Imaging, 760-929-2840